Heather Lang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Heather Lang has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Christopher Charles Winchester
Oxford PharmaGenesis, Oxford, UK
2 shared publications Oxford Oxford PharmaGenesis
2 shared publicationsOxford PharmaGenesis
2 shared publications- Tim Koder
Oxford PharmaGenesis Ltd, Oxford, UK
2 shared publications Arne Svejgaard
1 shared publicationChristina Andersson
1 shared publication
Latest Publications
- 22 January 2019
- Published by Oxford Pharmagenesis
Does publication with open access enhance article impact?
- 22 January 2019
- Published by Oxford Pharmagenesis
Does publication with open access enhance article impact?
- 30 April 2018
- Published by Oxford Pharmagenesis
Is pharmaceutical industry research posted as preprints?
- 30 April 2018
- Published by Oxford Pharmagenesis
Is pharmaceutical industry research posted as preprints?
- 3 September 2002
- Published by Springer Nature in Nature Immunology
- Vol. 3 (10) , 940-943
A functional and structural basis for TCR cross-reactivity in multiple sclerosis
The multiple sclerosis (MS)-associated HLA major histocompatibility complex (MHC) class II alleles DRB1*1501, DRB5*0101 and DQB1*0602 are in strong linkage disequilibrium, making it difficult to determine which is the principal MS risk gene. Here we show that together the DRB1 and DRB5 loci may influence susceptibility to MS. We demonstrate that a T cell receptor (TCR) from an MS patient recognized both a DRB1*1501-restricted myelin basic protein (MBP) and DRB5*0101-restricted Epstein-Barr virus (EBV) peptide. Crystal structure determination of the DRB5*0101-EBV peptide complex revealed a marked degree of structural equivalence to the DRB1*1501-MBP peptide complex at the surface presented for TCR recognition. This provides structural evidence for molecular mimicry involving HLA molecules. The structural details suggest an explanation for the preponderance of MHC class II associations in HLA-associated diseases.
- 3 September 2002
- Published by Springer Nature in Nature Immunology
- Vol. 3 (10) , 940-943
A functional and structural basis for TCR cross-reactivity in multiple sclerosis
The multiple sclerosis (MS)-associated HLA major histocompatibility complex (MHC) class II alleles DRB1*1501, DRB5*0101 and DQB1*0602 are in strong linkage disequilibrium, making it difficult to determine which is the principal MS risk gene. Here we show that together the DRB1 and DRB5 loci may influence susceptibility to MS. We demonstrate that a T cell receptor (TCR) from an MS patient recognized both a DRB1*1501-restricted myelin basic protein (MBP) and DRB5*0101-restricted Epstein-Barr virus (EBV) peptide. Crystal structure determination of the DRB5*0101-EBV peptide complex revealed a marked degree of structural equivalence to the DRB1*1501-MBP peptide complex at the surface presented for TCR recognition. This provides structural evidence for molecular mimicry involving HLA molecules. The structural details suggest an explanation for the preponderance of MHC class II associations in HLA-associated diseases.